About Glimperide & Metformin Combinations
Glimperide & Metformin Combinations are formulated to aid in the effective management of Type 2 diabetes mellitus (NIDDM). The tablets combine two potent active ingredients: Glimperide, a sulfonylurea that stimulates insulin release from the pancreas, and Metformin, a biguanide that improves insulin sensitivity and reduces glucose production in the liver. Available in multiple formulations tailored to varying medical needs, Euroglip-M1 contains Glimperide 1 mg and Metformin 500 mg, Euroglip-M2 incorporates Glimperide 2 mg and Metformin 500 mg, and Euroglip-Plus M2 delivers Glimperide 2 mg and Metformin 1000 mg. These tablets are manufactured for adults and aged persons, ensuring precise and reliable performance for diabetes management. Designed for export, these specific drug products meet stringent quality standards suitable for both patients and healthcare providers.
FAQs of Glimperide & Metformin Combinations:
Q: What are Glimperide & Metformin Combinations used for?
A: They are used for managing Type 2 diabetes mellitus (NIDDM).
Q: Who is this medication suitable for?
A: It is suitable for adults and aged persons.
Q: What active ingredients do these tablets contain?
A: They contain Glimperide (1 mg or 2 mg) and Metformin (500 mg or 1000 mg) depending on the formulation.
Q: How does Glimperide & Metformin work?
A: Glimperide stimulates insulin release, while Metformin improves insulin sensitivity and reduces glucose production in the liver.
Q: Are these products available for export?
A: Yes, these products are manufactured and supplied for export.